Document Detail


Improving vascular function in hypertension: potential benefits of combination therapy with amlodipine and renin-angiotensin-aldosterone system blockers.
MedLine Citation:
PMID:  19797978     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hypertension is characterized by endothelial dysfunction and increased risk for adverse cardiovascular outcomes. In addition to lowering blood pressure, the calcium-channel blocker amlodipine and blockers of the renin-angiotensin-aldosterone system (angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers) may further reduce cardiovascular risk by improving endothelial function when used alone or in combination. In fact, the beneficial effects of the combination of amlodipine and a renin-angiotensin-aldosterone system blocker on endothelial function have been found to be greater than the effect of either drug alone, likely due to additive effects on nitric oxide activity. This review summarizes the observed effects of these agents on endothelial function and the complementary mechanisms by which they act, thus providing rationale (beyond blood pressure benefits) for their use in combination.
Authors:
Helmy M Siragy
Related Documents :
19021028 - Aldosterone as an independent factor in cerebrovascular damage.
912848 - Urinary kallikrein in normal renin essential hypertension.
11154148 - Hormonal hypertension in children: 11beta-hydroxylase deficiency and apparent mineraloc...
17606858 - Effects of fenofibrate on cardiac remodeling in aldosterone-induced hypertension.
8820788 - A theoretic analysis of the effect of pulmonary vasodilation on pulmonary venous pressu...
2567708 - Bradykinin antagonism and prostaglandins in blood pressure regulation.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review    
Journal Detail:
Title:  Journal of hypertension     Volume:  28     ISSN:  1473-5598     ISO Abbreviation:  J. Hypertens.     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2009-12-17     Completed Date:  2010-03-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8306882     Medline TA:  J Hypertens     Country:  England    
Other Details:
Languages:  eng     Pagination:  2-8     Citation Subset:  IM    
Affiliation:
Department of Medicine, Hypertension Center, University of Virginia, Charlottesville, Virginia 22908, USA. hms7a@virginia.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amlodipine / therapeutic use*
Angiotensin II Type 1 Receptor Blockers / therapeutic use*
Antihypertensive Agents / therapeutic use*
Blood Vessels / drug effects*,  physiopathology
Drug Therapy, Combination
Endothelium, Vascular / drug effects,  physiopathology
Humans
Hypertension / drug therapy*,  physiopathology
Renin-Angiotensin System / drug effects*,  physiology
Grant Support
ID/Acronym/Agency:
DK-078757/DK/NIDDK NIH HHS; HL-091535/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Angiotensin II Type 1 Receptor Blockers; 0/Antihypertensive Agents; 88150-42-9/Amlodipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Initial presentation of pheochromocytoma with Takotsubo cardiomyopathy: a brief review of literature...
Next Document:  Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implicati...